We collected information about Immuneregen Biosciences Inc Hours for you. Follow the liks to find out everything about Immuneregen Biosciences Inc Hours.
https://finance.yahoo.com/quote/IRBS/profile/
U.S. markets close in 5 hours 55 minutes. S&P 500 4,495.29 +25.29 (+0.57%) ... ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary ...
https://www.bloomberg.com/profile/company/206439Z:US
ImmuneRegen BioSciences Inc. ImmuneRegen BioSciences Inc. is a biotechnology company that researches and develops applications utilizing modified Substance P, a naturally occurring immunomodulator.
https://www.linkedin.com/company/immuneregen-biosciences
ImmuneRegen BioSciences is engaged in the research and development of the drug candidate, Homspera® for use as an immunomodulatory agent and stimulator of human adult stem cells.
https://money.cnn.com/news/newsfeeds/articles/marketwire/0648386.htm
Aug 05, 2010 · ImmuneRegen BioSciences Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC BB: IRBS.OB), is a development-stage biotechnology …
https://eresearch.fidelity.com/eresearch/evaluate/snapshot.jhtml?symbols=IRBS
Aug 17, 2021 · View more. IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia.
https://www.biospace.com/article/releases/immuneregen-biosciences-inc-announces-results-from-recent-radilex-tm-study-/
Oct 24, 2005 · About ImmuneRegen BioSciences, Inc. IR BioSciences Holdings Inc., through its wholly owned subsidiary ImmuneRegen BioSciences, Inc., is developing Homspera(TM) and its derivatives Radilex(TM) and Viprovex(TM) as a family of countermeasures for multiple homeland security threats, including chemical agents, Acute Radiation Sickness (ARS) from a ...
https://www.biospace.com/article/releases/-b-immuneregen-biosciences-b-meets-with-the-new-york-state-office-of-public-security/
Feb 14, 2005 · SCOTTSDALE, Ariz., Feb. 14 /PRNewswire/ -- ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (BULLETIN BOARD: IRBO) announced it recently met with the New York State Office of Public/Homeland Security (NYSOPS), the agency responsible for the detection, identification, response, prevention, and recovery from a terrorist act or threat in New York State.
Searching for Immuneregen Biosciences Inc Hours?
You can just click the links above. The info is collected for you.
